Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Tandlægeholdingselskabet Tore Lefolii ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.5% 0.5%   Bankruptcy risk   3.1% 5.8% 2.0% 2.3% 1.7% 2.5% 8.2% 8.2%   Credit score (0-100)   58 41 69 63 72 61 30 30   Credit rating   BBB BBB A BBB A BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.2 0.0 2.7 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,816 1,288 1,060 776 532 -329 0.0 0.0   EBITDA   136 1,114 1,006 771 532 -329 0.0 0.0   EBIT   126 1,038 917 680 440 -405 0.0 0.0   Pre-tax profit (PTP)   86.7 1,035.3 391.9 100.3 2,221.7 5,748.4 0.0 0.0   Net earnings   63.1 785.8 286.6 61.4 2,211.5 5,947.6 0.0 0.0   Pre-tax profit without non-rec. items   86.7 1,035 392 100 2,222 5,748 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   217 329 270 179 87.2 11.6 0.0 0.0   Shareholders equity total   462 294 580 585 2,740 6,537 6,290 6,290   Interest-bearing liabilities   31.5 1.9 8,844 9,054 10,940 6,400 0.0 0.0   Balance sheet total (assets)   1,441 830 10,408 10,701 15,831 13,906 6,290 6,290   Net Debt   -832 -104 8,587 8,848 10,788 4,197 -6,290 -6,290     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,816 1,288 1,060 776 532 -329 0.0 0.0   Gross profit growth   72.5% -29.1% -17.7% -26.8% -31.4% 0.0% 0.0% 0.0%   Employees   0 1 1 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,441 830 10,408 10,701 15,831 13,906 6,290 6,290   Balance sheet change%   81.1% -42.4% 1,154.6% 2.8% 47.9% -12.2% -54.8% 0.0%   Added value   136.2 1,114.2 1,006.2 771.1 531.6 -329.3 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   207 36 -148 -182 -183 -151 -12 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 -1.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   6.9% 80.6% 86.5% 87.7% 82.8% 123.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   11.3% 92.7% 16.4% 6.7% 20.2% 42.6% 0.0% 0.0%   ROI %   26.7% 262.2% 18.9% 7.4% 23.0% 47.6% 0.0% 0.0%   ROE %   13.8% 208.0% 65.6% 10.5% 133.0% 128.2% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   32.1% 35.4% 5.6% 5.5% 17.3% 47.0% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -610.7% -9.3% 853.4% 1,147.4% 2,027.6% -1,274.5% 0.0% 0.0%   Gearing %   6.8% 0.7% 1,523.9% 1,547.2% 399.3% 97.9% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   249.8% 98.0% 11.9% 6.7% 4.6% 6.7% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.2 0.8 0.3 0.3 0.7 1.0 0.0 0.0   Current Ratio   1.2 0.8 0.3 0.3 0.7 1.0 0.0 0.0   Cash and cash equivalent   863.3 105.5 257.1 206.5 152.3 2,203.2 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   230.1 -79.9 -1,944.9 -3,302.1 -2,217.0 198.8 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 1,114 1,006 771 532 -329 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 1,114 1,006 771 532 -329 0 0   EBIT / employee   0 1,038 917 680 440 -405 0 0   Net earnings / employee   0 786 287 61 2,212 5,948 0 0